Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study - PubMed (original) (raw)
Clinical Trial
. 2009 Jan-Feb;13(1):51-5.
Affiliations
- PMID: 19364085
Clinical Trial
Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study
D A De Luis et al. Eur Rev Med Pharmacol Sci. 2009 Jan-Feb.
Abstract
Background and objectives: Epidemiological and interventional studies suggest that a high dietary intake of n-3 polyunsaturated fatty acids may confer a protective effect against atherosclerotic disease and reduce serum triglycerides levels. The aim of our study was to investigate the effectivity on triglyceride levels and inflammatory markers of a concentrated of n-3 fatty acids in patients with type 2 diabetes mellitus and hypertriglyceridaemia.
Subjects: A total of 30 patients (16 males and 14 females) with diabetes mellitus type 2 and hypertriglyceridemia (> 200 mg/dl) were included in the study. Patients received two capsules of eicosapentaenoic 465 mg and docosahexanoic 375 mg daily for 12 weeks.
Results: Triglycerides levels and non HDL-cholesterol decreased (326 +/- 113.5 vs. 216.4 +/- 57 mg/dl; p < 0.05) and (103.87 +/- 44 vs. 89.6 +/- 14 mg/dl; p < 0.05), respectively. HDL-cholesterol levels increased (39.6 +/- 10.7 vs. 46.4 +/- 8.7 mg/dl; p < 0.05). C reactive protein decreased (5.98 +/- 3.9 vs. 3.9 +/- 1.6 mg/dl; p < 0.05) and TNF-alpha levels decreased (16.24 +/- 5.5 vs. 13.3 +/- 5.8 pg/dl; p < 0.05), without significant changes in IL-6 levels. In conclusion, an n-3 polyunsaturated intervention improved lipid profile and inflammatory markers in patients with diabetes mellitus type 2 and hypertriglyceridaemia.
Similar articles
- Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN; COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Davidson MH, et al. Clin Ther. 2007 Jul;29(7):1354-67. doi: 10.1016/j.clinthera.2007.07.018. Clin Ther. 2007. PMID: 17825687 Clinical Trial. - Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM, Sica D. McKenney JM, et al. Pharmacotherapy. 2007 May;27(5):715-28. doi: 10.1592/phco.27.5.715. Pharmacotherapy. 2007. PMID: 17461707 Review. - Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE. Burns T, et al. Pharmacotherapy. 2007 May;27(5):633-8. doi: 10.1592/phco.27.5.633. Pharmacotherapy. 2007. PMID: 17461697 Clinical Trial. - What can we expect from omega-3 fatty acids?
Chan EJ, Cho L. Chan EJ, et al. Cleve Clin J Med. 2009 Apr;76(4):245-51. doi: 10.3949/ccjm.76a.08042. Cleve Clin J Med. 2009. PMID: 19339640 Review. - Safety and efficacy of Omacor in severe hypertriglyceridemia.
Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K. Harris WS, et al. J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):385-91. J Cardiovasc Risk. 1997. PMID: 9865671 Clinical Trial.
Cited by
- Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis.
Natto ZS, Yaghmoor W, Alshaeri HK, Van Dyke TE. Natto ZS, et al. Sci Rep. 2019 Dec 11;9(1):18867. doi: 10.1038/s41598-019-54535-x. Sci Rep. 2019. PMID: 31827125 Free PMC article. - Nutritional properties of dietary omega-3-enriched phospholipids.
Murru E, Banni S, Carta G. Murru E, et al. Biomed Res Int. 2013;2013:965417. doi: 10.1155/2013/965417. Epub 2013 Jul 31. Biomed Res Int. 2013. PMID: 23984423 Free PMC article. Review. - Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.
Jiao J, Liu G, Shin HJ, Hu FB, Rimm EB, Rexrode KM, Manson JE, Zong G, Sun Q. Jiao J, et al. BMJ. 2019 Jul 2;366:l4009. doi: 10.1136/bmj.l4009. BMJ. 2019. PMID: 31266749 Free PMC article. - Fasting Triglyceride Concentrations are Associated with Early Mortality Following Antiretroviral Therapy in Zambia.
Ngu JN, Heimburger DC, Arnett DK, Nyirenda CK, Potter D, Zulu I, Bosire CN, Bagchi S, Ye J, Chi BH, Kabagambe EK. Ngu JN, et al. N Am J Med Sci (Boston). 2010;3(2):79-88. doi: 10.7156/v3i2p079. N Am J Med Sci (Boston). 2010. PMID: 22059107 Free PMC article. - (n-3) Fatty Acids: Clinical Trials in People with Type 2 Diabetes.
Hendrich S. Hendrich S. Adv Nutr. 2010 Nov;1(1):3-7. doi: 10.3945/an.110.1003. Epub 2010 Nov 16. Adv Nutr. 2010. PMID: 22043446 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials